Menu
24 Oct 2017 | 1:29 PM
 

Bharat Immunological & Biologicals Corporation Ltd. Share Price Live (BSE)
0

BSE Code: 524663 | NSE Symbol:
22.50
0.15
(0.68 %)
24 Oct 2017 | 01:19 PM
Change company
  • Open (Rs)
    22.50
  • Prev. close (Rs.)
    22.35
  • High (Rs.)
    23.20
  • Low (Rs.)
    22.30
  • 52W H (Rs.)
    38.40
  • 52W L (Rs.)
    17.50
  • Volume
    61204
  • MCap (Rs in Cr.)
    97.16
F&O Futures F&O Options
Expiry Date
  • Open (Rs)
  • High (Rs)
  • Low (Rs)
  • Prev. close(Rs)
  • Contracts Tra.
  • Turnover (Cr.)
  • Open Interest
  • Open Int. chg
1D| 1W| 1M | 3M | 6M | 1YR | MAX

Financials

News

Bharat Immunolog posts Q1 net loss of Rs 1.98 cr
25 Jul 2017 - 14:00:00-Net sales of the company declined substantially by 87.95 per cent at Rs 3...
Bharat Immunologicals net profit surges by 142 per cent
13 May 2016 - 14:35:00-Bharat Immunologicals & Biologicals Corporation Ltd net profit surge by 142 per cent

Net pro...

Announcements

16-Oct-2017
Bharat Immunolog - Shareholding for the Period Ended September 30 2017
14-Oct-2017
Bharat Immunolog - Board Meeting On 25 October 2017
07-Sep-2017
Bharat Immunolog - Submission Of Draft 28Th Annual Report Of The Company Which Will Be Placed At Shareholders On 29.09.2017
30-Aug-2017
Bharat Immunolog - Fixes Book Closure for AGM
29-Aug-2017
Bharat Immunolog - Intimation Of Book Closure Period From 23.09.2017 To 29.09.2017 For Twenty Eighth Annual General Meeting S

Religare Research

Metals & Energy Weekly Report
23 Oct 2017 | 07:25 PM
• Gold prices rebounded from two month lows on Friday as fresh concerns over tensions with North Kor...
Tech Stars-23rd October-2017
23 Oct 2017 | 06:30 PM
Tech Stars, comprises our 2 top stock picks filtered on the basis of momentum from our coverage univ...
Daily Forex and IRF Report
23 Oct 2017 | 10:46 AM
Indian rupee closed little changed with marginal losses against the US dollar as traders avoided tak...
Daily Techno Funda
23 Oct 2017 | 09:33 AM
Gold dipped as dollar gained after US Senate cleared tax reform hurdle  Crude oil rose on tighter f...

Fund Interest

Schemes Shares Held Mkt. Value Latest Nav % Nav
No Data Available

Shareholding Pattern

      
Promotors59.25%
Mutual Funds/UTI0.00%
FI/Banks0.00%
Insurance0.00%
FII0.00%
Government0.00%
Others5.08%

Peer Group

Company Intraday Graph
 Merck Ltd.
1,142.00(-1.42)
 3302
 Neuland Laboratories Ltd.
1,113.50(0.86)
 3578
 Kovai Medical Center and Hospital Ltd.
1,100.00(0.77)
 11816
 Hester Biosciences Ltd.
1,080.00(-0.25)
 3572

Exchange Information

NSE Index
Sensex
CNX 100
BSENAT
CNX 200
BSE200
CNX Bank
BSE500
CNX500
BSE Midcap
CNX Midcap
BSE Smallcap
Note: The scrip is a constituent of those NSE and BSE indices that have against them.

Company Indices

 1M (%)3M (%)6M (%)
Bharat Immunological & Biologicals Corporation Ltd.1.30-6.95-4.90
NIFTY(S&P CNX)340.05248.10994.70
BSE SENSEX934.21314.972,905.00
BSE 500560.17460.341,382.31

Corporate Details

Key Personal
Chandra Prakash Goyal
Managing Director
M K Bhan
Chairman
Veena Tamta Bhatia
Managing Director
Key Address
Registered Office
BIBCOL OPV Plant Village Chola,Bulandshahar Dist,Uttar Pradesh

Tel:05732-238758 238763-68 238210, Fax:05732-238757

complianceofficer_bibcol@yahoo.in
http://www.bibcol.com
Registrar Office
Beetal Financial & Computer Services (P) Ltd
Add. :Beetal House 3rd Floor 99 Madangir Behind Local Shopping Centre Near Dada Harsukhdas Mandir
QUICK LINKS
RELIGARE ONLINE
IMPORTANT LINKS
EXPLORE RELIGARE
Stocks Directory
Mutual Funds Directory
Investor Complaints
Attention Investors

Prevent unauthorized transactions in your account - Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day - Issued in the interest of Investors.

Prevent Unauthorized Transactions in your demat account Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from Depository (NSDL/CDSL) on the same day issued in the interest of investors.

No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investors account.

KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

Trading and Demat Accounts opened under Insta Plan will not be eligible for dealing through branches.
Follow us on
Unified Portal Version No.1.0.0.1
Copyright 2010 Religare. Trademarks are the property of their respective owners. All rights reserved.
Religare Securities Limited, Registered Office:2nd Floor, Rajlok Building, 24, Nehru Place, New Delhi-110019. Board line number 011-46272400, Fax No. 011-46272447
Religare is a registered trademark of RHC Holding Private Limited used under license by Religare Enterprises Limited and its subsidiaries.
  • Member :
  • NSE: SEBI Regn. No: INB 230653732, INF 230653732 & INE 230653732 TM Co: 06537
  • Clearing Member (F&O) No. M50235 BSE:SEBI Regn. No: INB 010653732 & INF 010653732 |
  • Clearing No: 3004 |
  • MSEI SEBI Regn. No: INB260653739, INF260653739 & INE260653732 TM Co: 1051 Clearing Member (F&O) No. 51 |
  • NSDL: DP ID: IN 301774 |
  • SEBI Regn. No: IN-DP-NSDL-150-2000 |
  • CDSL DP ID: 30200 SEBI Regn. No: IN-DP-CDSL-202-2003 |
  • Research Analyst SEBI Regi. No.: INH100001831 |
    Religare Commodities Limited- Registered Office:2nd Floor, Rajlok Building, 24, Nehru Place, New Delhi-110019. Board line number 011-46272400, Fax No. 011-46272447
  • Member :
  • NCDEX: Member ID - 00109 |
  • MCX: Member ID - 10575 |
  • SEBI Registration Number- INZ000022334|
  • NSEL Member ID- 10180 |
  • NCDEX Emarket Member ID - 10042 |
The Site is best viewed with screen resolution 1024x768. The compatible browsers are Mozilla Firefox, Google Chrome and IE 8 (or above)